Brimonidine Tartrate 0.25% / Potassium Azeloyl Diglycinate 8%
Product Images NDC 72934-1027

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate 0.25% / Potassium Azeloyl Diglycinate 8% (NDC 72934-1027). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ds (2 End)

Side label of BRIMONIDINE TARTRATE 0.25% / POTASSIUM AZELOYL DIGLYCINATE 8% container. The label includes directions for use stating to apply topically as directed by a physician, and advises external use only with hand washing after use. The storage condition is controlled room temperature (20-25°C). Labeler information shows Sincerus Florida LLC, Pompano Beach, FL, with contact numbers for adverse reaction reporting and a QR code at the bottom.*

FDA Label Image

D (1027 2 Front)

Packaging label for BRIMONIDINE TARTRATE USP 0.25% gel in a 30 gram container. The label displays the NDC 72934-1027-2 and features the Sincerus Florida logo with teal and orange colors. The product is identified as a compounded drug made in the USA.*

FDA Label Image

F (1027 2 Middle)

Partial label of BRIMONIDINE TARTRATE 0.25% / POTASSIUM AZELOYL DIGLYCINATE 8% gel showing active ingredients and inactive ingredients list. Active ingredients include Brimonidine Tartrate USP 0.25%. Inactive ingredients include Kriskel 100, Potassium Azeloyl Diglycinate 8%, and Suspension Gel 50%. The label mentions Rx only, a lot number, and manufacturing and expiration dates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.